This week's Fierce Biotech is brought to you by Sengenics Corporation.

Webinar: Circulating and Local Antibodies as Novel Cancer Biomarkers

Wednesday, June 28, 2023 | 11am ET / 8am PT

Circulating and local antibodies are revolutionizing cancer diagnosis and treatment. Analyzing circulating antibody characteristics and dynamics delivers important insights into the bi-directional engagement between the immune system and tumors. This helps to identify novel blood-based biomarkers which can result in the discovery of novel cancer therapies.

Join industry experts for this important one-hour discussion to explore:

• How antibody profiling has been used to successfully identify novel diagnostic, prognostic, therapeutic, and predictive biomarkers in melanoma, prostate cancer, breast cancer, ovarian cancer, and rare cancers
• The process for obtaining a unique snapshot of the tumor which circumvents the influence of inter- and intra- tumor heterogeneity that affect tissue-based techniques
• Examples of the promising results and advances in cancer research
• And more